🔴 CalciMedica is trading 6.1% down in pre-market with no verified catalyst identified

CalciMedica is trading 6.1% down at $1.00, with no verified company-specific catalyst identified; the reason remains uncertain.

• No verified company-specific announcement dated October 20 or October 21 was found to explain the pre-market decline.
• The reported $25 million at-the-market offering dates to October 1, not this morning.
• Biotech was up 3.64% pre-market, opposite CalciMedica’s move; the available evidence does not establish a cause.